| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 23/02/2018 | 14:27 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 16/02/2018 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 15/02/2018 | 22:49 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 15/02/2018 | 00:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 22:10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 21:51 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 17:17 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 16:59 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 16:19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 15:26 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 15:16 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 13/02/2018 | 15:08 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 06/02/2018 | 23:53 | PR Newswire (US) | Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600 | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 16/01/2018 | 22:55 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 16/01/2018 | 22:34 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 27/12/2017 | 23:31 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 26/12/2017 | 13:43 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 26/12/2017 | 12:45 | PR Newswire (US) | Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 28/11/2017 | 12:35 | PR Newswire (US) | Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 27/11/2017 | 22:10 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 21/11/2017 | 22:10 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 09/11/2017 | 23:48 | GlobeNewswire Inc. | Sucampo to Host 2017 R&D Day on November 16 in New York | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/11/2017 | 21:13 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/11/2017 | 11:37 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/11/2017 | 11:30 | GlobeNewswire Inc. | Sucampo Reports Third Quarter 2017 Financial Results | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 23/10/2017 | 22:05 | GlobeNewswire Inc. | Sucampo Announces Third Quarter 2017 Earnings Call | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 28/09/2017 | 23:35 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with... | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 28/09/2017 | 02:43 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 21/09/2017 | 14:25 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & ... | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 20/09/2017 | 22:15 | GlobeNewswire Inc. | Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |